======= SCGB1A1 ======= == Gene Information == * **Official Symbol**: SCGB1A1 * **Official Name**: secretoglobin family 1A member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7356|7356]] * **UniProt**: [[https://www.uniprot.org/uniprot/P11684|P11684]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SCGB1A1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SCGB1A1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/192020|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the secretoglobin family of small secreted proteins. The encoded protein has been implicated in numerous functions including anti-inflammation, inhibition of phospholipase A2 and the sequestering of hydrophobic ligands. Defects in this gene are associated with a susceptibility to asthma. [provided by RefSeq, May 2010]. * **UniProt Summary**: Binds phosphatidylcholine, phosphatidylinositol, polychlorinated biphenyls (PCB) and weakly progesterone, potent inhibitor of phospholipase A2. |Uteroglobin| |polychlorinated biphenyl binding| |response to silicon dioxide| |response to ozone| |negative regulation of interleukin-4 production| |phospholipase A2 inhibitor activity| |negative regulation of interleukin-5 production| |negative regulation of interleukin-13 production| |regulation of interleukin-13 production| |regulation of interleukin-5 production| |regulation of interleukin-4 production| |negative regulation of interferon-gamma production| |embryo implantation| |rough endoplasmic reticulum| |negative regulation of T cell proliferation| |negative regulation of mononuclear cell proliferation| |negative regulation of lymphocyte proliferation| |negative regulation of leukocyte proliferation| |secretory granule| |regulation of interferon-gamma production| |negative regulation of T cell activation| |response to fibroblast growth factor| |negative regulation of leukocyte cell-cell adhesion| |negative regulation of lymphocyte activation| |response to glucocorticoid| |regulation of T cell proliferation| |response to corticosteroid| |negative regulation of cell-cell adhesion| |negative regulation of leukocyte activation| |nuclear envelope| |regulation of mRNA stability| |female pregnancy| |regulation of RNA stability| |response to reactive oxygen species| |negative regulation of cell activation| |regulation of mRNA catabolic process| |regulation of lymphocyte proliferation| |regulation of mononuclear cell proliferation| |multi-multicellular organism process| |regulation of leukocyte proliferation| |negative regulation of cell adhesion| |negative regulation of cytokine production| |regulation of leukocyte cell-cell adhesion| |response to xenobiotic stimulus| |response to antibiotic| |response to lipopolysaccharide| |regulation of T cell activation| |response to molecule of bacterial origin| |response to steroid hormone| |regulation of mRNA metabolic process| |regulation of inflammatory response| |response to acid chemical| |response to oxidative stress| |regulation of cell-cell adhesion| |negative regulation of immune system process| |regulation of lymphocyte activation| |posttranscriptional regulation of gene expression| |response to growth factor| |response to inorganic substance| |regulation of leukocyte activation| |regulation of cell activation| |negative regulation of cell population proliferation| |regulation of cell adhesion| |response to bacterium| |regulation of cytokine production| |regulation of defense response| |negative regulation of catalytic activity| |regulation of cellular catabolic process| |response to lipid| |negative regulation of transcription by RNA polymerase II| |response to hormone| |response to organic cyclic compound| |regulation of catabolic process| |multi-organism reproductive process| |response to drug| |regulation of response to external stimulus| |response to cytokine| |negative regulation of molecular function| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |reproductive process| |reproduction| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |extracellular space| |regulation of cell population proliferation| |regulation of immune system process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|-2.28| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18843 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}